Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125705881 | 12570588 | 1 | I | 20160623 | 20160706 | 20160719 | 20160719 | EXP | FR-VALIDUS PHARMACEUTICALS LLC-FR-2016VAL002284 | VALIDUS | 91.00 | YR | F | Y | 0.00000 | 20160719 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125705881 | 12570588 | 1 | PS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | (STRENGTH: 500 MG) 250 MG, DAILY | Y | 16273 | 250 | MG | TABLET | ||||||
| 125705881 | 12570588 | 2 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | (STRENGTH: 500 MG) UNK | Y | 16273 | TABLET | ||||||||
| 125705881 | 12570588 | 3 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | (STRENGTH 40 MG) UNK, TWICE A DAY | Y | 16273 | TABLET | ||||||||
| 125705881 | 12570588 | 4 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | (STRENGTH 40 MG) UNK | Y | 16273 | TABLET | ||||||||
| 125705881 | 12570588 | 5 | C | SEROPLEX | ESCITALOPRAM OXALATE | 1 | UNK | U | 0 | ||||||||||
| 125705881 | 12570588 | 6 | C | BISOPROLOL | BISOPROLOL | 1 | UNK | U | 0 | ||||||||||
| 125705881 | 12570588 | 7 | C | COUMADIN | WARFARIN SODIUM | 1 | UNK | U | 0 | ||||||||||
| 125705881 | 12570588 | 8 | C | ALLOPURINOL. | ALLOPURINOL | 1 | UNK | U | 0 | ||||||||||
| 125705881 | 12570588 | 9 | C | KAYEXALATE | SODIUM POLYSTYRENE SULFONATE | 1 | UNK | U | 0 | ||||||||||
| 125705881 | 12570588 | 10 | C | LEVOTHYROX | LEVOTHYROXINE | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125705881 | 12570588 | 1 | Chronic kidney disease |
| 125705881 | 12570588 | 5 | Product used for unknown indication |
| 125705881 | 12570588 | 6 | Product used for unknown indication |
| 125705881 | 12570588 | 7 | Product used for unknown indication |
| 125705881 | 12570588 | 8 | Product used for unknown indication |
| 125705881 | 12570588 | 9 | Product used for unknown indication |
| 125705881 | 12570588 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125705881 | 12570588 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125705881 | 12570588 | Dehydration | |
| 125705881 | 12570588 | Hyponatraemia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125705881 | 12570588 | 1 | 20160623 | 0 | ||
| 125705881 | 12570588 | 3 | 201603 | 20160623 | 0 | |
| 125705881 | 12570588 | 4 | 201603 | 20160623 | 0 | |
| 125705881 | 12570588 | 5 | 20160623 | 0 |